These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 11668840)

  • 1. Record settlement on TAP. Drugmaker pleads guilty to criminal violations.
    Taylor M
    Mod Healthc; 2001 Oct; 31(41):8. PubMed ID: 11668840
    [No Abstract]   [Full Text] [Related]  

  • 2. Tapped for $800 million. Drugmakers' joint venture will pay what could be biggest fraud settlement.
    Taylor M
    Mod Healthc; 2001 Apr; 31(17):8-9. PubMed ID: 11338904
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmaceutical company to pay $875 million to settle federal case.
    Young D
    Am J Health Syst Pharm; 2001 Nov; 58(22):2121, 2124. PubMed ID: 11760910
    [No Abstract]   [Full Text] [Related]  

  • 4. Medicare reimbursement and prescribing hormone therapy for prostate cancer.
    Keating NL
    J Natl Cancer Inst; 2010 Dec; 102(24):1814-5. PubMed ID: 21131579
    [No Abstract]   [Full Text] [Related]  

  • 5. Implantable LHRH agonist for treatment of prostate cancer.
    Lajiness MJ
    Urol Nurs; 2006 Oct; 26(5):408, 414. PubMed ID: 17078331
    [No Abstract]   [Full Text] [Related]  

  • 6. States, safety net providers recover millions from Medicaid fraud schemes.
    Young D
    Am J Health Syst Pharm; 2004 Mar; 61(5):440. PubMed ID: 15018220
    [No Abstract]   [Full Text] [Related]  

  • 7. Company pleads guilty to falsely boosting HIV drug sales.
    AIDS Policy Law; 2005 May; 20(9):6. PubMed ID: 15912609
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment costs for advanced prostate cancer using luteinizing hormone-releasing hormone agonists: a solid biodegradable leuprorelin implant versus other formulations.
    Merseburger AS; Björk T; Whitehouse J; Meani D
    J Comp Eff Res; 2015 Sep; 4(5):447-53. PubMed ID: 25521079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cost effectiveness of GnRH antagonists in patients with prostate cancer and cardiovascular risk : Comparative analysis against Leuprorelin by the Number Needed to Treat].
    Anderson D; Lehmann J; Ecker T; Vosgerau S; Donatz V
    Urologe A; 2017 Jul; 56(7):917-924. PubMed ID: 28405705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness analysis comparing degarelix with leuprolide in hormonal therapy for patients with locally advanced prostate cancer.
    Hatoum HT; Crawford ED; Nielsen SK; Lin SJ; Marshall DC
    Expert Rev Pharmacoecon Outcomes Res; 2013 Apr; 13(2):261-70. PubMed ID: 23570437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Highmark settles charges; ex-VP pleads guilty.
    Hallam K
    Mod Healthc; 1998 Sep; 28(36):3. PubMed ID: 10185557
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of prostatic cancer with TAP-144-SR, a depot preparation of LH-RH agonist (leuprolide).
    Isurugi K; Niijima T; Akaza H; Aso Y; Koiso K; Fuse M; Okada K; Usami M; Ohashi T; Ueda T;
    J Chemother; 1989 Jul; 1(4 Suppl):1237-41. PubMed ID: 16312848
    [No Abstract]   [Full Text] [Related]  

  • 13. Sinking Medicaid fraud. Operator of N.Y. facilities pleads guilty; possible record settlement cited.
    Galloro V
    Mod Healthc; 2001 Apr; 31(17):35. PubMed ID: 11338900
    [No Abstract]   [Full Text] [Related]  

  • 14. Caveat medicus: consequences of federal investigations of marketing activities of pharmaceutical suppliers of prostate cancer drugs.
    McKoy JM; Lyons EA; Obadina E; Carson K; Pickard AS; Schellhammer P; McLeod D; Boyd CE; McWilliams N; Sartor O; Schumock GT; McCaffery K; Bennett CL
    J Clin Oncol; 2005 Dec; 23(34):8894-905. PubMed ID: 16314650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AstraZeneca to pay $355 million fine.
    FDA Consum; 2003; 37(5):3. PubMed ID: 14666886
    [No Abstract]   [Full Text] [Related]  

  • 16. Illinois Blues pleads guilty to fraud.
    Hallam K
    Mod Healthc; 1998 Jul; 28(29):3, 14. PubMed ID: 10182359
    [No Abstract]   [Full Text] [Related]  

  • 17. Criminal actions. Hospital pleads guilty to wire fraud for medically unnecessary procedures. U.S. v. United Memorial Hospital, No. 1:01-CR-238 (W.D. Mich. Jan. 8, 2003).
    West JC
    J Healthc Risk Manag; 2003; 23(3):36-7. PubMed ID: 15842165
    [No Abstract]   [Full Text] [Related]  

  • 18. N.Y. hospital to repay $84 million. Medicaid fraud settlement deal allows 'precedent-setting' 20-year payback schedule.
    Pallarito K
    Mod Healthc; 1999 Sep; 29(39):3, 13. PubMed ID: 10621435
    [No Abstract]   [Full Text] [Related]  

  • 19. Criminal RICO, Fighting Corruption and Fraud in Big Pharma - United States v. Michael L. Babich.
    Ortyl E
    Am J Law Med; 2019 Mar; 45(1):86-90. PubMed ID: 31293206
    [No Abstract]   [Full Text] [Related]  

  • 20. Recent case developments in health law. Pharmaceutical price-fixing and consumer protection: Blue Cross & Blue Shield v. AstraZeneca Pharmaceuticals LP.
    Clark S
    J Law Med Ethics; 2010; 38(1):160-2. PubMed ID: 20446995
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.